Celebrating 30 years of helping you give wisely
America's most independent,
assertive charity watchdog
Top Rated

Cancer Research Institute

CharityWatch report issued
November 2021

Top-Rated Charity
CharityWatch Grade
Our independent grade based
on a number of factors.
Program Percentage
Amount spent on programs
relative to overhead.
Cost to Raise $100
Amount spent to raise
$100 of contributions.

Contact Information

Cancer Research Institute
29 Broadway
Floor 4
New York, NY 10006-3111

Other Names


Tax Status


Stated Mission

To save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.

View similar charities
American Breast Cancer Foundation  
American Cancer Society  
American Institute for Cancer Research  
Avon Products Foundation  
Breast Cancer Charities of America (DISSOLVED)  
Breast Cancer Outreach Foundation (DISSOLVED)  
Breast Cancer Prevention Partners  
Breast Cancer Research Foundation  
Breast Cancer Society (DISSOLVED)  
Cancer Fund of America (DISSOLVED)  
Cancer Recovery Foundation International  
Cancer Survivors' Fund (DISSOLVED)  
Childhood Leukemia Foundation  
Children's Cancer Fund of America (DISSOLVED)  
Children's Cancer Recovery Foundation (DISSOLVED)  
Children's Cancer Research Fund  
Children's Leukemia Research Association  
CureSearch for Children's Cancer  
Damon Runyon Cancer Research Foundation  
Dana-Farber Cancer Institute  
Entertainment Industry Foundation / Stand Up To Cancer  
Good Charity (DISSOLVED)  
Leukemia & Lymphoma Society  
Livestrong Foundation  
Memorial Sloan Kettering Cancer Center  
Multiple Myeloma Research Foundation  
National Breast Cancer Coalition Fund  
National Breast Cancer Foundation  
National Cancer Assistance Foundation  
National Cancer Center  
National Cancer Coalition (DISSOLVED)  
National Children's Cancer Society  
National Children's Leukemia Foundation (DISSOLVED)  
National Foundation for Cancer Research  
Ovarian Cancer Research Alliance  
Pancreatic Cancer Action Network  
Prevent Cancer Foundation  
Prostate Cancer Foundation  
St. Jude Children's Research Hospital  
Susan G. Komen Breast Cancer Foundation  
United Breast Cancer Foundation  
United Cancer Support Foundation  
Walker Cancer Research Institute  
Woman to Woman Breast Cancer Foundation (DISSOLVED)  
Data based on Fiscal Year Ended 06/30/2020

Program Percentage: 78%

The percentage of Cancer Research Institute's cash budget it spends on programs relative to overhead (fundraising, management, and general expenses).


Calculated Total Expenses



Cost to Raise $100: $18

How many dollars Cancer Research Institute spends on fundraising to raise each $100 of contributions.


Calculated Total Contributions


Joint Costs

Cancer Research Institute's rating was adjusted for Joint Costs. If you are a donor who considers direct mail, telemarketing, and other Joint Cost solicitations to be true charitable programs, the below efficiency ratios, which were not adjusted for joint costs, may better reflect your goals.

Program % Cost to Raise $100
78% $17
Accounting rules allow charities to report some telemarketing, direct mail, and other solicitation costs as Program expenses. CharityWatch believes that most donors do not consider a charity's solicitation activities to be the Programs they are intending to support with their donations. We therefore adjust such expenses out of a charity's reported Program expense and add it to Fundraising expense prior to calculating its rating.

Government Funding

0% to 24%

Percentage of cash revenue
coming from government sources


Financial Documents

Entity Document Type Tax ID
Cancer Research Institute IRS Form 990 13-1837442
Cancer Research Institute Audited Financial Statements 13-1837442
Entity: Cancer Research Institute
Document Type: IRS Form 990
Tax ID: 13-1837442
Entity: Cancer Research Institute
Document Type: Audited Financial Statements
Tax ID: 13-1837442

Governance & Transparency

CharityWatch evaluates certain criteria related to a charity's Governance and Transparency. Donors may want to consider a charity's willingness to be open and transparent with CharityWatch to be a good litmus test for determining its commitment to public accountability.
This charity is Top-Rated
What does it mean to be Top-Rated?
Cancer Research Institute
meets governance benchmarks.
Cancer Research Institute
meets transparency benchmarks.
Provides Financial Information
Audit Accessibility
Governance: Policies
Reports regularly & consistently monitoring & enforcing compliance with a written Conflict of Interest Policy
Reports required, annual disclosure by officers, directors, and key staff of interests that could give rise to conflicts
Reports having a written Whistleblower Policy
Reports having a written Document Retention and Destruction Policy
Governance: Financials
Reports providing copy of tax form to all board members prior to filing it with IRS
Reports that financial statements were audited by an independent accountant
Governance: Board of Directors
Reports at least 5 voting board members
51% or more of voting board members reported as independent
Reports documenting minutes of board and board committee meetings
Privacy Policy
Privacy Policy No Sharing  

  Name Title Compensation
1 Jill O'Donnell-Tormey CEO/Director of Scientific Affairs $528,584
2 Alfred R. Massidas CFO/Director of Human Resources $375,411
3 Lynne A. Rapino Director of Grants Administration & Special Events $326,501
Name: Jill O'Donnell-Tormey
Title: CEO/Director of Scientific Affairs
Compensation: $528,584
Name: Alfred R. Massidas
Title: CFO/Director of Human Resources
Compensation: $375,411
Name: Lynne A. Rapino
Title: Director of Grants Administration & Special Events
Compensation: $326,501

CharityWatch Analysts perform an in-depth analysis of charities' audited financial statements and IRS tax filings, and often review other documents such as state filings, annual reports, and fundraising contracts during their evaluations. Below are select notes that CharityWatch believes may be of interest to donors.

According to the Cancer Research Institute audit of June 30, 2020 (Note A-16 re: Contributed services), the Institute received in-kind contributed services provided by the Institute's Scientific Advisory Council in fiscal 2020 on which it placed a total value of $564,130.

[Note: CharityWatch generally excludes the value of in-kind (non-cash) donations of goods and services from its calculations of Program % and Cost to Raise $100. More information on how grades are calculated and the treatment of in-kind donations can be found on the Our Process page.]

According to the Cancer Research Institute audit of June 30, 2020 (Note B-1, Contributions and grants receivable):

"...Included in contribution revenue for fiscal-years 2020 and 2019, was an amount of $5,917,456 from one donor and $17,634,069 from two donors, respectively, which represented approximately 15% and 40%, respectively, of the total operating support and revenue for each fiscal year."

According to the Cancer Research Institute audit of June 30, 2020 (Note E, PPP Loan Payable):

"On March 27, 2020, Congress enacted the Coronavirus Aid, Relief, and Economic Security Act ('CARES Act'). The PPP [Paycheck Protection Program], established by the CARES Act, and implemented by the SBA [Small Business Administration], provides businesses, including certain not-for-profit organizations, with funds to pay payroll and other costs during [the] Coronavirus ('COVID-19') outbreak... On May 1, 2020, the Institute received $710,150 in funds from the PPP... Neither principle nor interest is due for a six-month deferral period through November 2020. This loan may be forgiven subject to bank approval in accordance with SBA guidelines. Any outstanding principle of the loan that is not forgiven under the PPP Loan program at the end of the six-month deferral period will convert to a term loan with an interest rate of 1% payable in equal installments of principle and interest over the next eighteen months beginning in December 2020. The loan matures May 1, 2022. The Institute is in the process of applying for forgiveness..."

According to the Cancer Research Institute audit of June 30, 2020 (Note N-2, Other uncertainty):

"The extent of the impact and effects of the recent outbreak of COVID-19 on the operation and financial performance of the Institute's business will depend on future developments, including the duration and spread of the outbreak, related travel advisories and restrictions, and the consequential potential of staff shortages, all of which are highly uncertain and cannot be predicted. If demands for the Institute's services are impacted for an extended period, the Institute's results of operations may be materially adversely affected."